We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
ATP5ME
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • ATP5ME
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

ATP5ME is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 609.35
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 929.8
Number of samples 362
Samples
Sample Description pTPM
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 4060.3
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 3685.5
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 3247.3
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 3108.0
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 2917.7
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 2861.9
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 2676.4
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 2439.3
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 2405.3
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 2362.9
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 2348.9
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 2190.5
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 2085.5
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 2071.8
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 1906.9
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 1849.6
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 1808.3
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 1800.0
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 1781.0
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 1771.0
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 1757.4
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 1742.8
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 1734.7
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 1670.4
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 1667.9
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 1666.4
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 1621.4
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 1613.2
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 1599.0
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 1597.9
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 1553.9
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 1543.8
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 1540.6
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 1520.8
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 1465.2
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 1447.3
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 1447.2
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 1435.6
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 1404.7
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 1399.4
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 1388.1
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 1358.0
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 1357.6
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 1351.0
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 1337.6
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 1337.4
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 1329.1
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 1318.6
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 1309.8
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 1309.1
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 1297.3
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 1291.4
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 1290.4
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 1280.7
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 1280.7
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 1277.8
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 1273.2
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 1266.6
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 1260.4
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 1257.7
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 1252.5
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 1243.4
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 1237.3
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 1230.7
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 1227.4
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 1221.7
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 1215.3
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 1209.9
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 1205.1
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 1203.4
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 1178.7
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 1173.9
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 1162.8
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 1162.7
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 1161.5
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 1151.8
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 1150.4
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 1149.9
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 1147.4
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 1142.2
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 1137.2
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 1132.7
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 1131.2
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 1129.5
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 1122.5
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 1118.0
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 1101.9
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 1098.4
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 1091.2
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 1088.8
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 1087.1
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 1086.1
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 1084.2
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 1081.9
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 1066.3
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 1066.0
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 1059.3
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 1059.1
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 1058.9
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 1057.8
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 1052.1
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 1045.6
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 1045.1
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 1042.8
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 1028.9
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 1027.6
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 1025.5
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 1017.5
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 1015.8
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 1012.0
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 1009.5
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 1006.6
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 1006.5
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 1005.8
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 1001.0
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 1000.4
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 990.3
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 983.5
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 971.4
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 966.6
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 965.2
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 963.7
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 960.7
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 958.1
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 957.4
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 950.2
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 947.1
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 941.8
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 932.5
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 931.1
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 930.3
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 926.1
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 925.8
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 924.4
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 924.0
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 919.4
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 917.7
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 916.2
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 907.2
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 901.0
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 899.5
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 896.9
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 896.8
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 888.5
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 886.3
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 883.3
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 883.1
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 879.6
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 878.0
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 877.9
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 875.5
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 875.1
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 874.3
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 871.3
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 868.5
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 867.8
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 866.5
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 865.5
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 864.2
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 860.7
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 857.7
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 857.5
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 854.8
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 847.0
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 845.9
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 842.2
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 840.2
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 839.6
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 831.2
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 828.4
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 825.6
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 824.3
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 821.4
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 821.1
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 820.3
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 817.6
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 809.5
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 801.5
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 801.1
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 794.6
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 794.5
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 791.1
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 790.9
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 783.7
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 782.8
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 782.7
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 782.2
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 782.0
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 779.7
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 775.6
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 774.7
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 774.5
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 772.7
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 771.9
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 771.8
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 763.9
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 762.6
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 762.6
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 759.0
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 759.0
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 757.7
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 757.6
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 755.0
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 753.8
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 753.7
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 752.2
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 751.9
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 737.1
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 734.2
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 733.3
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 733.2
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 723.7
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 723.6
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 723.1
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 722.1
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 721.2
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 719.6
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 718.0
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 715.9
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 715.9
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 715.7
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 709.6
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 706.0
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 702.6
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 699.7
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 699.0
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 696.3
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 695.7
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 694.0
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 693.7
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 692.5
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 690.2
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 690.1
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 689.9
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 688.7
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 687.1
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 686.7
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 679.3
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 675.8
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 674.6
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 673.3
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 670.2
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 665.6
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 663.8
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 659.9
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 658.5
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 657.4
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 655.2
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 654.3
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 653.2
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 652.8
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 652.4
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 650.1
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 648.5
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 648.0
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 647.7
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 646.4
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 644.7
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 644.6
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 639.5
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 639.4
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 631.1
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 628.5
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 623.9
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 623.7
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 622.7
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 621.4
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 620.7
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 620.4
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 619.6
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 617.6
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 616.4
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 616.0
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 615.7
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 612.4
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 611.7
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 610.8
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 610.1
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 609.9
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 608.8
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 608.6
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 605.7
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 602.6
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 598.0
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 595.2
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 588.4
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 587.6
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 586.8
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 585.6
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 582.2
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 580.8
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 573.4
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 573.1
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 571.8
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 569.9
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 566.4
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 563.9
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 563.6
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 562.6
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 561.5
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 559.9
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 558.3
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 557.9
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 556.4
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 554.5
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 554.5
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 550.6
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 547.0
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 545.1
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 544.6
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 544.6
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 543.1
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 541.4
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 540.5
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 539.1
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 534.6
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 531.8
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 531.1
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 530.0
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 529.0
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 528.2
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 523.1
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 521.7
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 510.7
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 509.1
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 506.9
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 506.6
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 505.0
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 504.6
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 503.3
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 503.3
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 502.1
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 502.0
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 488.1
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 483.1
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 478.5
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 467.3
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 466.1
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 463.5
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 459.2
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 458.4
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 457.2
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 456.7
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 455.7
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 452.5
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 447.1
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 443.8
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 442.1
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 434.0
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 431.2
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 423.0
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 416.8
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 414.1
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 402.4
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 394.0
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 383.3
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 337.5
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 332.9
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 331.1
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 325.9
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 323.4
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 278.9
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

  Survival analysis data not available.
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
627 Tumor 1.4
513 Tumor 1.0
1043 Tumor 0.9
1025 Tumor 0.9
922 Normal 0.8
448 Normal 0.8
1045 Tumor 0.8
882 Normal 0.7
824 Normal 0.7
756 Normal 0.7
745 Tumor 0.7
912 Normal 0.7
515 Tumor 0.7
571 Tumor 0.7
227 Tumor 0.7
818 Normal 0.7
534 Normal 0.7
1032 Normal 0.7
1014 Normal 0.6
1046 Normal 0.6
982 Normal 0.6
823 Tumor 0.6
361 Tumor 0.6
714 Normal 0.6
868 Normal 0.6
487 Tumor 0.6
723 Tumor 0.6
862 Normal 0.6
472 Normal 0.6
488 Normal 0.6
785 Tumor 0.6
564 Normal 0.6
944 Normal 0.6
938 Normal 0.6
722 Normal 0.6
695 Tumor 0.6
1022 Normal 0.6
864 Normal 0.6
464 Normal 0.6
858 Normal 0.5
958 Normal 0.5
746 Normal 0.5
356 Normal 0.5
1042 Normal 0.5
738 Normal 0.5
852 Normal 0.5
918 Normal 0.5
924 Normal 0.5
456 Normal 0.5
786 Normal 0.5
698 Normal 0.5
484 Normal 0.5
546 Normal 0.5
1044 Normal 0.5
514 Normal 0.5
328 Normal 0.5
452 Normal 0.5
1013 Tumor 0.5
462 Normal 0.5
713 Tumor 0.5
925 Tumor 0.5
568 Normal 0.5
926 Normal 0.5
1026 Normal 0.5
964 Normal 0.5
984 Normal 0.5
128 Normal 0.5
436 Normal 0.5
416 Normal 0.5
162 Normal 0.5
412 Normal 0.5
528 Normal 0.5
365 Tumor 0.5
394 Normal 0.5
742 Normal 0.5
228 Normal 0.5
981 Tumor 0.5
923 Tumor 0.4
232 Normal 0.4
616 Normal 0.4
978 Normal 0.4
636 Normal 0.4
364 Normal 0.4
878 Normal 0.4
426 Normal 0.4
728 Normal 0.4
388 Normal 0.4
954 Normal 0.4
494 Normal 0.4
648 Normal 0.4
915 Tumor 0.4
1041 Tumor 0.4
466 Normal 0.4
136 Normal 0.4
696 Normal 0.4
1027 Tumor 0.4
423 Tumor 0.4
716 Normal 0.4
414 Normal 0.4
518 Normal 0.4
615 Tumor 0.4
618 Normal 0.4
428 Normal 0.4
344 Normal 0.4
867 Tumor 0.4
474 Normal 0.4
424 Normal 0.4
816 Normal 0.4
866 Normal 0.4
446 Normal 0.4
755 Tumor 0.4
916 Normal 0.4
952 Normal 0.4
572 Normal 0.3
686 Normal 0.3
914 Normal 0.3
465 Tumor 0.3
258 Normal 0.3
483 Tumor 0.3
517 Tumor 0.3
1016 Normal 0.3
286 Normal 0.3
863 Tumor 0.3
628 Normal 0.3
376 Normal 0.3
874 Normal 0.3
526 Normal 0.3
314 Normal 0.3
284 Normal 0.3
741 Tumor 0.3
358 Normal 0.3
956 Normal 0.3
142 Normal 0.3
196 Normal 0.3
482 Normal 0.3
298 Normal 0.3
967 Tumor 0.3
172 Normal 0.3
222 Normal 0.3
432 Normal 0.3
278 Normal 0.3
976 Normal 0.3
966 Normal 0.3
873 Tumor 0.3
422 Normal 0.3
727 Tumor 0.3
148 Normal 0.3
114 Normal 0.3
363 Tumor 0.2
1028 Normal 0.2
362 Normal 0.2
392 Normal 0.2
132 Normal 0.2
558 Normal 0.2
955 Tumor 0.2
664 Normal 0.2
1031 Tumor 0.2
524 Normal 0.2
354 Normal 0.2
537 Tumor 0.2
214 Normal 0.2
968 Normal 0.2
884 Normal 0.2
342 Normal 0.2
468 Normal 0.2
411 Tumor 0.2
666 Normal 0.2
111 Normal 0.2
523 Tumor 0.2
393 Tumor 0.2
778 Normal 0.2
352 Normal 0.2
396 Normal 0.2
386 Normal 0.2
366 Normal 0.2
224 Normal 0.2
212 Normal 0.2
332 Normal 0.2
138 Normal 0.1
327 Tumor 0.1
257 Tumor 0.1
574 Normal 0.1
415 Tumor 0.1
525 Tumor 0.1
536 Normal 0.1
538 Normal 0.1
272 Normal 0.1
145 Tumor 0.1
697 Tumor 0.1
516 Normal 0.1
491 Tumor 0.1
186 Normal 0.1
744 Normal 0.1
662 Normal 0.1
953 Tumor 0.1
461 Tumor 0.1
368 Normal 0.1
353 Tumor 0.1
911 Tumor 0.1
777 Tumor 0.1
218 Normal 0.1
642 Normal 0.1
312 Normal 0.1
554 Normal 0.1
477 Tumor 0.1
672 Normal 0.1
857 Tumor 0.1
481 Tumor 0.1
451 Tumor 0.1
635 Tumor 0.1
492 Normal 0.1
478 Normal 0.0
188 Normal 0.0
262 Normal 0.0
527 Tumor 0.0
146 Normal 0.0
498 Normal 0.0
921 Tumor 0.0
721 Tumor 0.0
815 Tumor 0.0
557 Tumor -0.1
434 Normal -0.1
443 Tumor -0.1
563 Tumor -0.1
957 Tumor -0.1
427 Tumor -0.1
261 Tumor -0.1
137 Tumor -0.1
951 Tumor -0.1
113 Tumor -0.1
126 Normal -0.1
268 Normal -0.1
267 Tumor -0.1
341 Tumor -0.1
861 Tumor -0.1
937 Tumor -0.1
425 Tumor -0.1
553 Tumor -0.1
737 Tumor -0.1
715 Tumor -0.1
221 Tumor -0.2
473 Tumor -0.2
851 Tumor -0.2
685 Tumor -0.2
384 Normal -0.2
1021 Tumor -0.2
231 Tumor -0.2
433 Tumor -0.2
617 Tumor -0.2
124 Normal -0.2
171 Tumor -0.2
567 Tumor -0.2
444 Normal -0.2
431 Tumor -0.2
387 Tumor -0.2
355 Tumor -0.3
493 Tumor -0.3
1015 Tumor -0.3
191 Tumor -0.3
192 Normal -0.3
533 Tumor -0.3
391 Tumor -0.3
187 Tumor -0.3
161 Tumor -0.3
447 Tumor -0.3
663 Tumor -0.3
977 Tumor -0.3
883 Tumor -0.3
983 Tumor -0.3
195 Tumor -0.3
421 Tumor -0.3
641 Tumor -0.4
297 Tumor -0.4
357 Tumor -0.4
217 Tumor -0.4
743 Tumor -0.4
455 Tumor -0.4
814 Normal -0.4
963 Tumor -0.4
913 Tumor -0.4
112 Tumor -0.4
127 Tumor -0.4
223 Tumor -0.4
135 Tumor -0.4
313 Tumor -0.4
271 Tumor -0.4
535 Tumor -0.4
813 Tumor -0.4
647 Tumor -0.5
471 Tumor -0.5
285 Tumor -0.5
351 Tumor -0.5
435 Tumor -0.5
141 Tumor -0.5
917 Tumor -0.5
497 Tumor -0.5
213 Tumor -0.5
975 Tumor -0.5
573 Tumor -0.5
125 Tumor -0.5
665 Tumor -0.6
943 Tumor -0.6
463 Tumor -0.6
881 Tumor -0.6
865 Tumor -0.6
147 Tumor -0.6
185 Tumor -0.6
817 Tumor -0.6
413 Tumor -0.6
445 Tumor -0.6
383 Tumor -0.7
211 Tumor -0.7
385 Tumor -0.7
467 Tumor -0.7
724 Normal -0.7
375 Tumor -0.7
367 Tumor -0.7
877 Tumor -0.8
395 Tumor -0.8
131 Tumor -0.8
965 Tumor -0.8
671 Tumor -0.8
331 Tumor -0.8
277 Tumor -0.8
311 Tumor -1.0
123 Tumor -1.0
343 Tumor -1.0
661 Tumor -1.0
283 Tumor -1.1
545 Tumor -1.1
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA035010
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Cholangiocarcinoma
Carcinoma, Hepatocellular, NOS

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org